NCT00480805已完成3 期
HYZAAR Versus Ramipril Diabetic Patients
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 312
- 主要终点
- To determine the antihypertensive effectiveness of HYZAAR as compared to Ramipril as measure by SiSBP at Week 4
研究概览
简要总结
A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is at least 18 years old, has been diagnosed with type 2 diabetes mellitus
排除标准
- •Patient has renal disease, malignant hypertension, uncontrolled type 2 diabetes mellitus, history of stroke, TIA (Transient Ischemic Attacks) , or heart disease
结局指标
主要结局
To determine the antihypertensive effectiveness of HYZAAR as compared to Ramipril as measure by SiSBP at Week 4
次要结局
- To determine the safety anf tolerability of HYZAAR as compared to Ramipril as seen in overall adverse experiences for the duration of the study
研究者
相似试验
进行中（未招募）
4 期
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesType 2 DiabetesNCT05433584Eli Lilly and Company780
已完成
2 期
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type IINCT01194258Halozyme Therapeutics132
Unknown
2 期
Daratumumab in HLA Desensitization Prior to TransplantationCardiac TransplantNCT05300451Barry A. Boilson10
已完成
1 期
The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy VolunteersAtrial FibrillationNCT04764201Hanmi Pharmaceutical Company Limited50
已完成
2 期
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusDiabetes Mellitus, Type 1NCT01194245Halozyme Therapeutics135